Sometimes numbers tell a story, but sometimes they obscure one. According to the latest figures from the National Cancer Institute, the death rate for people diagnosed with bladder cancer has hardly budged during the past 30 years. But experts who treat the disease tell a different and more hopeful tale—and they credit a surge in clinical trials for much of it.

Topics:  dr stephen a boorjian   rochester   minn    ldquo;clinical   dr guru sonpavde   dana-farber cancer institute   harvard medical school   boston   like boorjian   dr ashish kamat   md anderson cancer center   part   clinicaltrials   u.s national library   medicine   md anderson   dana-farber   latest breakthroughs that could help bladder cancer patients   let&rsquo   it&rsquo   changing cancer care   so patients no longer feel like   number   what&rsquo   changing   the national cancer institute   improving    ldquo;the   national cancer institute    boorjian   boorjian   mayo clinic   sonpavde   dana-farber    clinical   kamat   md anderson    houston   read   research   people   treatment   drugs   provide   therapies   standard   current   major   years   study   ways   immune   risk   you’ll   intervention   diagnosed   work   led   good   group   metastatic   professor   don’t   areas   fit   cases   promising   disease   team   treatments   treat   risks   cost   advancements   story   non-muscle-invasive   cells   called   hand   person’s   experiment   access   director   checkpoint   inhibitors   system   figures   lot   ldquo;this   ldquo;for   cancers   exploring   experts   important   effective   specific   ensure   tumors   ldquo;we’re   case   ldquo;in   target   invasive   setting   space   designed   recruiting   hadn’t   meet   institutions   potential   coming   benefit   identified   explains   type   advances   information   alternatives   screening   subject   medications   genetic   live   affiliated   results   words   
BING NEWS:
  • Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer
    Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, indicate patients undergoing surgery for localized muscle-invasive bladder ...
    10/2/2024 - 10:02 am | View Link
  • ASTRO 2024: Bladder Cancer
    The 2024 American Society for Radiation Oncology (ASTRO) annual meeting held in Washington D.C., between September 29 and October 2 was host to the session Presidential Symposium: Innovations in ...
    09/29/2024 - 2:30 am | View Link
  • Trimodal Therapy Shows Promise for Recurrent, High-Grade T1 Bladder Cancer
    Trimodal therapy may be an effective alternative to radical cystectomy for recurrent, high-grade T1 bladder cancer, according to a study published in the Journal of Clinical Oncology.
    09/25/2024 - 3:31 am | View Link
  • IBCN 2024: Elucidating the Response Rates to Additional BCG: Implications for Clinical Trial Design
    IBCN annual meeting included a bladder cancer session, featuring a presentation by Dr. Amanda Myers discussing the elucidation of response rates to additional BCG and implications for clinical trial ...
    09/20/2024 - 4:03 am | View Link
  • FORT-2 trial shows promising results for bladder cancer immunotherapy combination
    Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.
    09/19/2024 - 1:30 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News